Nick Neilio

Penn Capital Management Co LLC (Penn Capital) is an independent, SEC-registered investment advisor headquartered in Philadelphia, Pennsylvania. The firm was founded by Richard Hocker and Marcia Hocker in 1987 as Penn Capital Management Co., Inc. Penn Capital provides investment advisory services primarily through the following investment vehicles: registered mutual funds, private investment funds, separately managed accounts, and investment advisory programs offered through wrap fee programs or model portfolio distribution channels.

Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve.

Drexel Hamilton LLC is a registered broker-dealer headquartered in New York City. The firm was founded in 2007 and is a subsidiary of Drexel Hamilton Holdings LLC. Drexel Hamilton provides underwriting and executing securities transactions for corporations, municipalities and financial institutions. They offer meaningful employment opportunities for service-disabled veterans in the field of financial services.

Part of Jacobs Financial Group, Inc., FS Investments, Inc. is a company that provides surety services. The company is based in Charleston, WV. FS Investments was acquired by NELX, Inc. on June 05, 2001.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

State Administration of Foreign Exchange (Investment Management) (SAFE) is the investment management division of the Chinese Government's State Administration of Foreign Exchange. Headquartered in Beijing, the firm was founded in 1978 to draft rules and regulations governing foreign exchange market activities and to manage China's foreign exchange reserves for the People's Bank of China. SAFE also establishes central sub-branches and sub-branches in some cities and counties.

GKFO LLC is an independent, SEC-registered investment advisor and wealth management firm headquartered in West Conshohocken, Pennsylvania. The firm was founded by Christopher C. Geczy and Stephen R. Kitching in 2009. GKFO provides highly customized, client-centric wealth management to a limited number of high-net-worth families.

Almanack Investment Partners LLC (Almanack) is a SEC-registered investment advisor headquartered in Wayne, Pennsylvania. The firm was founded in 2015 and is principally owned by Gadsden Group Holdings LLC. Almanack offers investment management services to individual and institutional clients through the use of model asset allocation portfolios.

Digitalis Ventures LLC (Digitalis Ventures) is a venture capital firm founded in 2016 by Geoffrey W. Smith. The firm is headquartered in New York.

Somatix, Inc. operates as a digital health company. It uses wearables to track unhealthy behaviors and send timely alerts to change the user?s behavior. The company was founded by Eran Ofir and Uri Schatzberg in 2015 and is headquartered in New York, NY.

Sunlight Fuels Pvt Ltd. is an Indian company that provides business and management consultancy services. The private company is based in New Delhi, India and was founded in 2014.

Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas.

MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.